Streetbeat News

Products Services

AMGN

Amgen's experimental obesity drug showed promising results in a mid-stage trial, with patients losing up to 20% of their weight after a year without plateauing. However, these results are at the lower end of Wall Street's expectations.

Portfolio Pulse from

November 26, 2024 | 12:30 pm

PSI

The Invesco Semiconductors ETF (PSI) is a smart beta ETF providing broad exposure to the Technology sector, specifically semiconductors. It was launched on June 23, 2005.

Portfolio Pulse from

November 26, 2024 | 12:30 pm

CRRFY

Carrefour, Europe's largest food retailer, expressed regret over tensions caused by its decision to exclude South American meat from its French shelves, which was seen as questioning its partnership with Brazilian agriculture.

Portfolio Pulse from

November 26, 2024 | 12:30 pm

RDIV

The Invesco S&P Ultra Dividend Revenue ETF (RDIV) is highlighted as a potential investment for those seeking broad exposure to the Large Cap Value segment of the US equity market. This passively managed ETF was launched on October 1, 2013.

Portfolio Pulse from

November 26, 2024 | 12:30 pm

AMGN

Amgen is set to host a webcast to discuss the Phase 2 results of Maritide and the progress of its development program. This event is scheduled for November 26, 2024, at 5 a.m. and is aimed at the investment community.

Portfolio Pulse from

November 26, 2024 | 12:15 pm

VSTM

Verastem Oncology will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference, with a live webcast available on their website. This event may provide insights into the company's future plans and developments in cancer treatment.

Portfolio Pulse from

November 26, 2024 | 12:15 pm

SWTX

SpringWorks Therapeutics will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on December 3, 2024.

Portfolio Pulse from

November 26, 2024 | 12:15 pm

MBCOF

Marvel Biosciences Corp. has announced promising new data from its preclinical Rett syndrome study and plans to discuss orphan and rare disease status with the FDA.

Portfolio Pulse from

November 26, 2024 | 12:15 pm

GLUE

Monte Rosa Therapeutics, a clinical-stage biotech company, will participate in the Piper Sandler Healthcare Conference. CEO Markus Warmuth will engage in a fireside chat on December 3, 2024.

Portfolio Pulse from

November 26, 2024 | 12:15 pm

INVA

Innoviva, Inc. (NASDAQ: INVA) will participate in the Citi 2024 Global Healthcare Conference, with CEO Pavel Raifeld engaging in a fireside chat. Innoviva is a diversified holding company with a focus on royalties, critical care, and infectious disease platforms.

Portfolio Pulse from

November 26, 2024 | 12:15 pm